» Articles » PMID: 20004982

Ryks: New Partners for Wnts in the Developing and Regenerating Nervous System

Overview
Journal Trends Neurosci
Specialty Neurology
Date 2009 Dec 17
PMID 20004982
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Conserved Ryk transmembrane proteins, tyrosine kinase-related Wnt receptors, are important during neurogenesis, axon guidance and synaptogenesis. Here, we review the increasingly complex biology of the Wnt/Ryk pathway, emphasizing the mechanisms by which Ryks transduce or sometimes block the Wnt signal. Recent studies reveal that Wnts signal through Ryk via multiple mechanisms, including nuclear translocation of their intracellular domains and pathways employing Src Family Kinases and members of the canonical Wnt pathway. We also discuss reports indicating that Wnt/Ryk axon guidance roles are evolutionarily conserved and Wnt/Ryk interactions are required for motoneuron target selection and synaptogenesis at the neuromuscular junction. Recent findings that injury-induced Wnt/Ryk pathway activation inhibits axon regeneration underscore the importance of further understanding this novel pathway.

Citing Articles

Wnt Signaling in Hepatocellular Carcinoma: Biological Mechanisms and Therapeutic Opportunities.

Zhu Y, He Y, Gan R Cells. 2024; 13(23).

PMID: 39682738 PMC: 11640042. DOI: 10.3390/cells13231990.


Decoding the molecular pathways governing trophoblast migration and placental development; a literature review.

Liu L, Tang L, Chen S, Zheng L, Ma X Front Endocrinol (Lausanne). 2024; 15:1486608.

PMID: 39665023 PMC: 11631628. DOI: 10.3389/fendo.2024.1486608.


Accurate Spatial Heterogeneity Dissection and Gene Regulation Interpretation for Spatial Transcriptomics using Dual Graph Contrastive Learning.

Yu Z, Yang Y, Chen X, Wong K, Zhang Z, Zhao Y Adv Sci (Weinh). 2024; 12(3):e2410081.

PMID: 39605202 PMC: 11744562. DOI: 10.1002/advs.202410081.


Emerging roles and biomarker potential of WNT6 in human cancers.

Ferreira J, Goncalves C, Costa B Cell Commun Signal. 2024; 22(1):538.

PMID: 39529066 PMC: 11552340. DOI: 10.1186/s12964-024-01892-4.


Therapeutic advances of targeting receptor tyrosine kinases in cancer.

Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A Signal Transduct Target Ther. 2024; 9(1):201.

PMID: 39138146 PMC: 11323831. DOI: 10.1038/s41392-024-01899-w.